Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 1/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.33 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.32 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.32 |
| ▸ | ESR1 | P03372 | 2/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 4/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | MPI | P34949 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13706166 | 0.89 | CYP11B1 (0.36) | PTGS2GPR84HSD17B1HSD17B2MEN1 | |
| SCHEMBL13706126 | 0.89 | HSD17B1 (0.38) | PTGS2ALOX5GPR84HSD17B1HSD17B2 | |
| SCHEMBL13520278 | 0.87 | PTGS2 (0.41) | PTGS2GPR84HSD17B1HSD17B2ESR1 | |
| SCHEMBL13706285 | 0.85 | CYP11B1 (0.41) | PTGS2GPR84HSD17B1HSD17B2MEN1 | |
| SCHEMBL13706271 | 0.85 | ESR1 (0.35) | PTGS2ALOX5GPR84ESR1ESR2 | |
| SCHEMBL13158630 | 0.81 | ESR1 (0.33) | GPR84HSD17B1HSD17B2ESR1ESR2 | |
| SCHEMBL13408823 | 0.80 | HPGD (0.34) | GPR84MEN1KMT2AKDM4ECYP11B1 | |
| SCHEMBL13706270 | 0.80 | KDM4E (0.34) | PTGS2GPR84MEN1KMT2AKDM4E | |
| SCHEMBL13408727 | 0.77 | ALDH1A1 (0.31) | CYP11B1HPGDALDH1A1 | |
| SCHEMBL13408873 | 0.77 | GPR84 (0.38) | ALOX5GPR84ESR1ESR2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090230852-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-09-17 | — | — | US | disclosed |
| US-20090230852-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090230852-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OXER1, L1CAM, RPL41 | PTGS2 4026/4885ALOX5 1545/4885GPR84 1446/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.